Sentence examples for molecular imaging technologies from inspiring English sources

Tumor targeting is of high clinical and biological relevance, and major efforts have been made to develop molecular imaging technologies for visualization of the disease markers in tissue.

need to be improved or developed and standardised to address the improvements in medical technology as well as new methods, e.g. particle therapy or new molecular imaging technologies.

In this paper we discuss the role of IT and information systems that support incorporation of surrogate biomarkers in the clinical development process, with emphasis on new molecular imaging technologies and associated IT requirements.

Overall, molecular imaging technologies are witnessing growing application in the fields of oncology, neurology, and cardiovascular disease (CVD), where they are likely to significantly impact diagnostic and therapeutic decision making.

Because many different cancer types share similar tumor microenvironment features, the ability to target these biomarkers has the potential to provide clinically translatable molecular imaging technologies for a spectrum of cancers and broad clinical applications.

The aim of this review is to report the preclinical results and clinical application of all molecular imaging studies completed until now for in vivo detection of c-MET in cancer, in order to be beneficial to development of molecular probe and the combination of molecular imaging technologies for in vivo evaluation of c-MET.

Imaging mass spectrometry (IMS) is a molecular imaging technology that can deliver such spatial information with high chemical specificity for various classes of biomolecules, including metabolites, lipids, peptides, and proteins.

In 1998, Mr. Meyerson founded the Radiology Corporation of America (RCOA), an innovator and early adopter of Positron Emission Tomography (PET), a new molecular imaging technology that improved the diagnosis and treatment of many diseases, including the early detection of cancer and Alzheimer's Disease.

Positron emission tomography (PET) is a molecular imaging technology that enables in vivo quantification of metabolic activity or receptor density, among other applications.

However, lately with the advance of radiochemistry and of molecular imaging technology, it became evident that PET could help novel drug development process.

Highly "tumor-specific" and "tumor cell signal-specific" PET radiopharmaceuticals are essential to meet the growing demand of radioisotope-based molecular imaging technology.